[Value of tumor markers in monitoring of cytotoxic treatment of non-small cell lung cancer].
Załeska
Monika
M
III Kliniki Chorób Płuc, Instytut Gruźlicy i Chorób Płuc w Warszawie.
D014408:Biomarkers, Tumor / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D003602:Cytotoxicity, Immunologic; D003603:Cytotoxins / Q000627:therapeutic use*; D006801:Humans; D007633:Keratins / Q000097:blood; D008175:Lung Neoplasms / Q000097:blood* / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D010751:Phosphopyruvate Hydratase / Q000097:blood; D011044:Poland
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D018997:Chorionic Gonadotropin, beta Subunit, Human; D003603:Cytotoxins; D007633:Keratins; D010751:Phosphopyruvate Hydratase